Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
11,286,449
-
Shares change
-
+702,006
-
Total reported value, excl. options
-
$65,021,940
-
Value change
-
+$4,162,337
-
Number of buys
-
21
-
Number of sells
-
-11
-
Price
-
$5.76
Significant Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q2 2017
41 filings reported holding CBAY - CYMABAY THERAPEUTICS INC - COM as of Q2 2017.
CYMABAY THERAPEUTICS INC - COM (CBAY) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11,286,449 shares
.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (1,840,044 shares), Abingworth LLP (1,600,000 shares), BAKER BROS. ADVISORS LP (1,291,775 shares), Versant Venture Management, LLC (1,048,601 shares), VANGUARD GROUP INC (991,633 shares), J. Goldman & Co LP (788,125 shares), Ghost Tree Capital, LLC (650,000 shares), Lombard Odier Asset Management (USA) Corp (526,665 shares), MILLENNIUM MANAGEMENT LLC (425,898 shares), and Boxer Capital, LLC (425,000 shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.